The SkinCeuticals Cell Cycle Catalyst serum is designed to target the visible signs of ageing, such as fine lines, unwanted pigmentation and dead skin cells.Powered by a 7.7% multi-acid complex, the formula is infused with a blend of AHAs and BHAs to improve the appearance of discolouration while exfoliating the skin's surface to maintain optimal hydration levels. 1% taurine lends visible brightening effects to enhance skin's radiance.Proven Results:After 1 Week:-18% appearance of fine lines-11% appearance of visible pores+12% appearance of skin radiance+10% appearance of skin clarityAfter 8 Weeks:-21% fine lines-16% discoloration-13% visible pores+15% radiance+16% visible improvement of blemish marksProtocol: An 8-week, single-center clinical trial clinical study was conducted on 78 females with Fitzpatrick type l-VI, ages 27-68, and mild to moderate wrinkles, fine lines, rough skin texture, uneven skin tone, dull complexion. Catalyst was applied once daily as directed. Efficacy and tolerance evaluations were conducted at baseline, post-application, week 1, week 4, and week 8.SkinCeuticals in-clinic treatments are available at Hale Country Club. Click to book your skin consultation and discover more about the SkinCeuticals Professional Facials and Peels available.
The SkinCeuticals Cell Cycle Catalyst serum is designed to target the visible signs of ageing, such as fine lines, unwanted pigmentation and dead skin cells.Powered by a 7.7% multi-acid complex, the formula is infused with a blend of AHAs and BHAs to improve the appearance of discolouration while exfoliating the skin's surface to maintain optimal hydration levels. 1% taurine lends visible brightening effects to enhance skin's radiance.Proven Results:After 1 Week:-18% appearance of fine lines-11% appearance of visible pores+12% appearance of skin radiance+10% appearance of skin clarityAfter 8 Weeks:-21% fine lines-16% discoloration-13% visible pores+15% radiance+16% visible improvement of blemish marksProtocol: An 8-week, single-center clinical trial clinical study was conducted on 78 females with Fitzpatrick type l-VI, ages 27-68, and mild to moderate wrinkles, fine lines, rough skin texture, uneven skin tone, dull complexion. Catalyst was applied once daily as directed. Efficacy and tolerance evaluations were conducted at baseline, post-application, week 1, week 4, and week 8.SkinCeuticals in-clinic treatments are available at Hale Country Club. Click to book your skin consultation and discover more about the SkinCeuticals Professional Facials and Peels available.